JPLA
IGC icon

Joseph P. Lucia & Associates’s IGC Pharma IGC Stock Holding History

Joseph P. Lucia & Associates’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-100
Closed – – 467
2019
Q4 		$0 Hold
100
– – ﹤0.01% 461
2019
Q3 		$0 Hold
100
– – ﹤0.01% 461
2019
Q2 		$0 Buy
+100
New +$141 ﹤0.01% 456

Other funds holding IGC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CFA
Carroll Financial Associates Charlotte, North Carolina $1.88B AUM 20.52% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
SFS
Sowell Financial Services North Little Rock, Arkansas $3.06B AUM 30.02% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Joseph P. Lucia & Associates's IGC Position: Q1 2020 in Review

Joseph P. Lucia & Associates sold out of IGC Pharma (IGC) in Q1 2020, closing a stake of 100 shares.

Joseph P. Lucia & Associates first reported a position in IGC in Q2 2019 and held it in 3 quarters. The position peaked at $0 in Q4 2019. 21 funds tracked by Wall St. Rank hold IGC as of Q1 2020.

  • Joseph P. Lucia & Associates reported no remaining IGC Pharma position as of Q1 2020 after selling out during the quarter.
  • Joseph P. Lucia & Associates sold 100 IGC Pharma shares in Q1 2020.
  • Joseph P. Lucia & Associates first reported a position in IGC Pharma in Q2 2019 and held it in 3 quarters.
  • Joseph P. Lucia & Associates's IGC Pharma position peaked at $0 in Q4 2019.
  • 21 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2020.

Based on Joseph P. Lucia & Associates's 13F filing for Q1 2020, filed 22 Apr 2020.